Evaluating peripheral blood inflammatory and metabolic biomarkers as predictors in diabetic retinopathy and diabetic macular edema

Purpose: To determine the correlation between serum inflammatory and metabolic biomarkers of patients with diabetic retinopathy (DR) and diabetic macular edema (DME). Methods: Serum samples were obtained from 100 diabetic patients. Patients were divided into three groups: group 1 (patients with no...

Full description

Bibliographic Details
Main Authors: Chewang U Bhutia, Prempal Kaur, Karamjit Singh, Sukhraj Kaur
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2023-01-01
Series:Indian Journal of Ophthalmology
Subjects:
Online Access:http://www.ijo.in/article.asp?issn=0301-4738;year=2023;volume=71;issue=6;spage=2521;epage=2525;aulast=Bhutia
_version_ 1797775075504553984
author Chewang U Bhutia
Prempal Kaur
Karamjit Singh
Sukhraj Kaur
author_facet Chewang U Bhutia
Prempal Kaur
Karamjit Singh
Sukhraj Kaur
author_sort Chewang U Bhutia
collection DOAJ
description Purpose: To determine the correlation between serum inflammatory and metabolic biomarkers of patients with diabetic retinopathy (DR) and diabetic macular edema (DME). Methods: Serum samples were obtained from 100 diabetic patients. Patients were divided into three groups: group 1 (patients with no DR, n = 27), group 2 (DR with DME, n = 34), and group 3 (DR without DME, n = 39). Serum concentrations of C-reactive protein (CRP) and interleukin-6 (IL-6) were measured by quantitative turbidimetric immunoassay and sandwich chemiluminescence immunoassay, respectively. Metabolic parameters such as glycated hemoglobin (HbA1c), total cholesterol, low-density lipoprotein (LDL), high-density lipoprotein (HDL), triglyceride (TG), serum creatinine, and blood urea were determined by automated analyzer om-360 after standardization. Results: The levels of IL-6 and CRP differed significantly in patients with DR and without DR (P < 0.001 and P = 0.045, respectively). We also found a positive correlation between IL-6 and CRP with the severity of DR. When DR patients with DME were compared to patients without DME, only IL-6 was observed to be significantly elevated (P < 0.001). None of the metabolic markers correlated significantly with DR and DME. Conclusion: Significantly raised levels of serum inflammatory biomarkers can be used to elucidate the significant role of inflammation in the pathogenesis of DR. Therefore, circulating biomarkers can serve as diagnostic and therapeutic predictors for monitoring the onset and progression of DR and DME.
first_indexed 2024-03-12T22:30:24Z
format Article
id doaj.art-41983307e2ac481991df421338c4d9d8
institution Directory Open Access Journal
issn 0301-4738
1998-3689
language English
last_indexed 2024-03-12T22:30:24Z
publishDate 2023-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Indian Journal of Ophthalmology
spelling doaj.art-41983307e2ac481991df421338c4d9d82023-07-21T15:15:02ZengWolters Kluwer Medknow PublicationsIndian Journal of Ophthalmology0301-47381998-36892023-01-017162521252510.4103/IJO.IJO_345_23Evaluating peripheral blood inflammatory and metabolic biomarkers as predictors in diabetic retinopathy and diabetic macular edemaChewang U BhutiaPrempal KaurKaramjit SinghSukhraj KaurPurpose: To determine the correlation between serum inflammatory and metabolic biomarkers of patients with diabetic retinopathy (DR) and diabetic macular edema (DME). Methods: Serum samples were obtained from 100 diabetic patients. Patients were divided into three groups: group 1 (patients with no DR, n = 27), group 2 (DR with DME, n = 34), and group 3 (DR without DME, n = 39). Serum concentrations of C-reactive protein (CRP) and interleukin-6 (IL-6) were measured by quantitative turbidimetric immunoassay and sandwich chemiluminescence immunoassay, respectively. Metabolic parameters such as glycated hemoglobin (HbA1c), total cholesterol, low-density lipoprotein (LDL), high-density lipoprotein (HDL), triglyceride (TG), serum creatinine, and blood urea were determined by automated analyzer om-360 after standardization. Results: The levels of IL-6 and CRP differed significantly in patients with DR and without DR (P < 0.001 and P = 0.045, respectively). We also found a positive correlation between IL-6 and CRP with the severity of DR. When DR patients with DME were compared to patients without DME, only IL-6 was observed to be significantly elevated (P < 0.001). None of the metabolic markers correlated significantly with DR and DME. Conclusion: Significantly raised levels of serum inflammatory biomarkers can be used to elucidate the significant role of inflammation in the pathogenesis of DR. Therefore, circulating biomarkers can serve as diagnostic and therapeutic predictors for monitoring the onset and progression of DR and DME.http://www.ijo.in/article.asp?issn=0301-4738;year=2023;volume=71;issue=6;spage=2521;epage=2525;aulast=Bhutiabiomarkersdiabetic macular edemadiabetic retinopathy
spellingShingle Chewang U Bhutia
Prempal Kaur
Karamjit Singh
Sukhraj Kaur
Evaluating peripheral blood inflammatory and metabolic biomarkers as predictors in diabetic retinopathy and diabetic macular edema
Indian Journal of Ophthalmology
biomarkers
diabetic macular edema
diabetic retinopathy
title Evaluating peripheral blood inflammatory and metabolic biomarkers as predictors in diabetic retinopathy and diabetic macular edema
title_full Evaluating peripheral blood inflammatory and metabolic biomarkers as predictors in diabetic retinopathy and diabetic macular edema
title_fullStr Evaluating peripheral blood inflammatory and metabolic biomarkers as predictors in diabetic retinopathy and diabetic macular edema
title_full_unstemmed Evaluating peripheral blood inflammatory and metabolic biomarkers as predictors in diabetic retinopathy and diabetic macular edema
title_short Evaluating peripheral blood inflammatory and metabolic biomarkers as predictors in diabetic retinopathy and diabetic macular edema
title_sort evaluating peripheral blood inflammatory and metabolic biomarkers as predictors in diabetic retinopathy and diabetic macular edema
topic biomarkers
diabetic macular edema
diabetic retinopathy
url http://www.ijo.in/article.asp?issn=0301-4738;year=2023;volume=71;issue=6;spage=2521;epage=2525;aulast=Bhutia
work_keys_str_mv AT chewangubhutia evaluatingperipheralbloodinflammatoryandmetabolicbiomarkersaspredictorsindiabeticretinopathyanddiabeticmacularedema
AT prempalkaur evaluatingperipheralbloodinflammatoryandmetabolicbiomarkersaspredictorsindiabeticretinopathyanddiabeticmacularedema
AT karamjitsingh evaluatingperipheralbloodinflammatoryandmetabolicbiomarkersaspredictorsindiabeticretinopathyanddiabeticmacularedema
AT sukhrajkaur evaluatingperipheralbloodinflammatoryandmetabolicbiomarkersaspredictorsindiabeticretinopathyanddiabeticmacularedema